loadpatents
name:-0.084421157836914
name:-0.072834014892578
name:-0.0048449039459229
Stamford; Andrew Patent Filings

Stamford; Andrew

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stamford; Andrew.The latest application filed is for "pyridinone- and pyridazinone-based compounds and uses thereof".

Company Profile
3.80.91
  • Stamford; Andrew - Morristown NJ
  • Stamford; Andrew - Chatham NJ
  • STAMFORD; Andrew - Rahway NJ US
  • Stamford; Andrew - Chatham Township NJ
  • STAMFORD; Andrew - Kenilworth NJ US
  • STAMFORD; Andrew - Shanghai NJ US
  • Stamford; Andrew - Stamford NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2,2-difluorodioxolo A.sub.2A receptor antagonists
Grant 11,046,714 - Amjad , et al. June 29, 2
2021-06-29
Pyridinone- And Pyridazinone-based Compounds And Uses Thereof
App 20200407339 - Hla; Timothy ;   et al.
2020-12-31
Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors
Grant 10,624,912 - Graham , et al.
2020-04-21
Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors
Grant 10,548,910 - Graham , et al. Fe
2020-02-04
Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors
Grant 10,544,155 - Zhang , et al. Ja
2020-01-28
Aminopyrazine compounds with A2A antagonist properties
Grant 10,472,347 - Kuang , et al. Nov
2019-11-12
Spirocyclic Quinolizine Derivatives Useful as HIV Integrase Inhibitors
App 20190040076 - Zhang; Yonglian ;   et al.
2019-02-07
Aminopyrazine Compounds With A2a Antagonist Properties
App 20180327385 - KUANG; Rongze ;   et al.
2018-11-15
Spirocyclic Pyridotriazine Derivatives Useful As HIV Integrase Inhibitors
App 20180325926 - Graham; Thomas H. ;   et al.
2018-11-15
Amido-Substituted Pyridotriazine Derivatives Useful As HIV Integrase Inhibitors
App 20180325927 - Graham; Thomas H. ;   et al.
2018-11-15
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
Grant 10,011,615 - Ali , et al. July 3, 2
2018-07-03
Substituted Quinolizine Derivatives Useful As Hiv Integrase Inhibitors
App 20180028509 - Yu; Tao ;   et al.
2018-02-01
Substituted quinolizine derivatives useful as HIV integrase inhibitors
Grant 9,861,620 - Yu , et al. January 9, 2
2018-01-09
Processes For The Preparation Of A Bace Inhibitor
App 20170233382 - Miller; Steven P. ;   et al.
2017-08-17
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20170197991 - Ali; Amjad ;   et al.
2017-07-13
Compounds inhibiting leucine-rich repeat kinase enzyme activity
Grant 9,688,654 - Miller , et al. June 27, 2
2017-06-27
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A.sub.2A antagonist properties
Grant 9,676,780 - Ali , et al. June 13, 2
2017-06-13
Mineralocorticoid receptor antagonists
Grant 9,511,052 - Cernak , et al. December 6, 2
2016-12-06
Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors
Grant 9,493,479 - Graham , et al. November 15, 2
2016-11-15
Compounds inhibiting leucine-rich repeat kinase enzyme activity
Grant 9,493,440 - Miller , et al. November 15, 2
2016-11-15
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity
App 20160289207 - DeMong; Duane ;   et al.
2016-10-06
Compounds inhibiting leucine-rich repeat kinase enzyme activity
Grant 9,440,952 - Miller , et al. September 13, 2
2016-09-13
Compounds inhibiting leucine-rich repeat kinase enzyme activity
Grant 9,416,126 - Miller , et al. August 16, 2
2016-08-16
Substituted Quinolizine Derivatives Useful As Hiv Integrase Inhibitors
App 20160228419 - Yu; Tao ;   et al.
2016-08-11
Bridged bicyclic piperidine derivatives and methods of use thereof
Grant 9,409,918 - Harris , et al. August 9, 2
2016-08-09
2,2-difluorodioxolo A2a Receptor Antagonists
App 20160214997 - Amjad; Ali ;   et al.
2016-07-28
Piperazine-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20160194330 - Ali; Amjad ;   et al.
2016-07-07
4-pyridone Derivative Compounds And Uses Thereof As Hiv Integrase Inhibitors
App 20160060272 - Graham; Thomas H. ;   et al.
2016-03-03
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity
App 20160009696 - Miller; Michael ;   et al.
2016-01-14
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity
App 20160009681 - Miller; Michael ;   et al.
2016-01-14
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity
App 20160009682 - Miller; Michael ;   et al.
2016-01-14
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity
App 20160009689 - Miller; Michael ;   et al.
2016-01-14
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20150361098 - Ali; Amjad ;   et al.
2015-12-17
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
Grant 9,156,872 - Girijavallabhan , et al. October 13, 2
2015-10-13
2'-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases
Grant 9,150,603 - Girijavallabhan , et al. October 6, 2
2015-10-06
Mineralocorticoid Receptor Antagonists
App 20150182503 - Cernak; Timothy A. ;   et al.
2015-07-02
Cyclic amide BACE-1 inhibitors having a benzamide substituent
Grant 9,062,007 - Cumming , et al. June 23, 2
2015-06-23
2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
Grant 9,061,041 - Girijavallabhan , et al. June 23, 2
2015-06-23
Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment
Grant 9,006,228 - Miller , et al. April 14, 2
2015-04-14
Pyrimidine ether derivatives and methods of use thereof
Grant 8,912,206 - Neelamkavil , et al. December 16, 2
2014-12-16
2'-azido Substituted Nucleoside Derivatives And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20140206640 - Girijavallabhan; Vinay ;   et al.
2014-07-24
Heterocyclic aspartyl protease inhibitors
Grant 8,778,980 - Zhu , et al. July 15, 2
2014-07-15
2'-cyano Substituted Nucleoside Derivatives And Methods Of Use Thereof Useful For The Treatment Of Viral Diseases
App 20140161770 - Girijavallabhan; Vinay ;   et al.
2014-06-12
2'-substituted Nucleoside Derivatives And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20140154211 - Girijavallabhan; Vinay ;   et al.
2014-06-05
Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity and diabetes
Grant 8,722,882 - Neustadt , et al. May 13, 2
2014-05-13
Substituted isoindolines as aspartyl protease inhibitors
Grant 8,722,708 - Stamford , et al. May 13, 2
2014-05-13
Substituted Cyclopropyl Compounds, Compositions Containing Such Compounds, And Methods Of Treatment
App 20140128368 - Miller; Michael ;   et al.
2014-05-08
Cyclic Amide Bace-1 Inhibitors Having A Benzamide Substituent
App 20140128361 - Cumming; Jared N. ;   et al.
2014-05-08
Substituted imidazolones, compositions containing such compounds and methods of use
Grant 8,633,231 - DeMong , et al. January 21, 2
2014-01-21
Aspartyl protease inhibitors
Grant 8,629,155 - Wu , et al. January 14, 2
2014-01-14
Cyclic amine BACE-1 inhibitors having a benzamide substituent
Grant 8,623,867 - Cumming , et al. January 7, 2
2014-01-07
Glucagon receptor antagonists, compositions, and methods for their use
Grant 8,623,818 - Greenlee , et al. January 7, 2
2014-01-07
Substituted piperazines as CB1 antagonists
Grant 8,623,873 - Gilbert , et al. January 7, 2
2014-01-07
Macrocyclic heterocyclic aspartyl protease inhibitors
Grant 8,557,798 - Iserloh , et al. October 15, 2
2013-10-15
Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
Grant 8,450,331 - Zhu , et al. May 28, 2
2013-05-28
Substituted Imidazolones, Compositions Containing Such Compounds And Methods Of Use
App 20130123315 - DeMong; Duane ;   et al.
2013-05-16
Bicyclic heterocycle derivatives and methods of use thereof
Grant 8,410,122 - Harris , et al. April 2, 2
2013-04-02
Spiro-imidazolone derivatives as glucagon receptor antagonists
Grant 8,361,959 - Stamford , et al. January 29, 2
2013-01-29
Heterocyclic Aspartyl Protease Inhibitors
App 20130018066 - Zhu; Zhaoning ;   et al.
2013-01-17
Cyclic Amine Bace-1 Inhibitors Having A Benzamide Substituent
App 20130004518 - Cumming; Jared N. ;   et al.
2013-01-03
Pyrimidine Ether Derivatives And Methods Of Use Thereof
App 20120289525 - Neelamkavil; Santhosh Francis ;   et al.
2012-11-15
Heterocyclic Aspartyl Protease Inhibitors
App 20120276118 - Zhu; Zhaoning ;   et al.
2012-11-01
Cyclic amine BACE-1 inhibitors having a benzamide substituent
Grant 8,278,334 - Cumming , et al. October 2, 2
2012-10-02
Heterocyclic Aspartyl Protease Inhibitors
App 20120231017 - ZHU; ZHAONING ;   et al.
2012-09-13
Aspartyl Protease Inhibitors
App 20120232064 - Wu; Yusheng ;   et al.
2012-09-13
Heterocyclic Aspartyl Protease Inhibitors
App 20120231018 - Zhu; Zhaoning ;   et al.
2012-09-13
Fused Bicyclic Pyrimidine Derivatives And Methods Of Use Thereof
App 20120232073 - Neelamkavil; Santhosh Francis ;   et al.
2012-09-13
Bridged Bicyclic Piperidine Derivatives And Methods Of Use Thereof
App 20120214805 - Harris; Joel M. ;   et al.
2012-08-23
Heterocyclic aspartyl protease inhibitors
Grant 8,183,252 - Zhu , et al. May 22, 2
2012-05-22
Aspartyl protease inhibitors
Grant 8,168,641 - Wu , et al. May 1, 2
2012-05-01
Bridged Bicyclic Heterocycle Derivatives And Methods Of Use Thereof
App 20120040975 - Neelamkavil; Santhosh Francis ;   et al.
2012-02-16
Preparation and use of compounds as aspartyl protease inhibitors
Grant 8,110,682 - McKittrick , et al. February 7, 2
2012-02-07
Aspartyl protease inhibitors
Grant 8,093,254 - Zhu , et al. January 10, 2
2012-01-10
Pentafluorosulpholane-containing Antidiabetic Compounds
App 20110313008 - Josien; Hubert B. ;   et al.
2011-12-22
Pyrimidine Derivatives As Gpcr Modulators For Use In The Treatment Of Obesity And Diabetes
App 20110263570 - Neustadt; Bernard R. ;   et al.
2011-10-27
Bicyclic Heterocycle Derivatives And Methods Of Use Thereof
App 20110263624 - Harris; Joel M. ;   et al.
2011-10-27
Heterocyclic Aspartyl Protease Inhibitors
App 20110218194 - Zhu; Zhaoning ;   et al.
2011-09-08
Spiro-imidazolone Derivatives As Glucagon Receptor Antagonists
App 20110178007 - Stamford; Andrew ;   et al.
2011-07-21
Heterocyclic aspartyl protease inhibitors
Grant 7,973,067 - Zhu , et al. July 5, 2
2011-07-05
Cyclic amine bace-1 inhibitors having a heterocyclic substituent
Grant 7,910,590 - Huang , et al. March 22, 2
2011-03-22
Glucagon Receptor Antagonists, Compositions, And Methods For Their Use
App 20110065634 - Greenlee; William J. ;   et al.
2011-03-17
Aspartyl protease inhibitors
Grant 7,868,000 - Zhu , et al. January 11, 2
2011-01-11
Heterocyclic Aspartyl Protease Inhibitors
App 20100292203 - Zhu; Zhaoning ;   et al.
2010-11-18
Macrocyclic heterocyclic aspartyl protease inhibitors
Grant 7,812,013 - Iserloh , et al. October 12, 2
2010-10-12
Substituted Piperazines As Cb1 Antagonists
App 20100249144 - Demong; Duane Eugene ;   et al.
2010-09-30
Diaryl Morpholines As Cb1 Modulators
App 20100197564 - Scott; Jack D. ;   et al.
2010-08-05
Heterocyclic aspartyl protease inhibitors
Grant 7,763,609 - Zhu , et al. July 27, 2
2010-07-27
Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatment
Grant 7,759,353 - Zhu , et al. July 20, 2
2010-07-20
Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof
Grant 7,759,354 - Zhu , et al. July 20, 2
2010-07-20
Cyclic Amine Bace-1 Inhibitors Having A Benzamide Substituent
App 20100152138 - Cumming; Jared N. ;   et al.
2010-06-17
Adenosine A.sub.a2 receptor antagonists
Grant 7,713,985 - Clasby , et al. May 11, 2
2010-05-11
Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A.sub.2a receptor antagonists
Grant 7,709,492 - Neustadt , et al. May 4, 2
2010-05-04
Heterocyclic aspartyl protease inhibitors
Grant 7,700,603 - Zhu , et al. April 20, 2
2010-04-20
Aspartyl Protease Inhibitors
App 20100069406 - Zhu; Zhaoning ;   et al.
2010-03-18
Macrocyclic Heterocyclic Aspartyl Protease Inhibitors
App 20100063121 - Iserloh; Ulrich ;   et al.
2010-03-11
Cyclic amine BACE-1 inhibitors having a benzamide substituent
Grant 7,662,816 - Cumming , et al. February 16, 2
2010-02-16
Aspartyl Protease Inhibitors Containing A Tricyclic Ring System
App 20100016341 - Zhu; Zhaoning ;   et al.
2010-01-21
Cyclic Amine Bace-1 Inhibitors Having A Heterocyclic Substituent
App 20090312341 - Cumming; Jared N. ;   et al.
2009-12-17
Heterocyclic Aspartyl Protease Inhibitors
App 20090306047 - Zhu; Zhaoning ;   et al.
2009-12-10
Heterocyclic Aspartyl Protease Inhibitors
App 20090258868 - Zhu; Zhaoning ;   et al.
2009-10-15
Cyclic amine BACE-1 inhibitors having a heterocyclic substituent
Grant 7,598,250 - Cumming , et al. October 6, 2
2009-10-06
Heterocyclic aspartyl protease inhibitors
Grant 7,592,348 - Zhu , et al. September 22, 2
2009-09-22
Substituted Piperazines as CB1 Antagonists
App 20090105208 - Gilbert; Eric J. ;   et al.
2009-04-23
2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
Grant 7,465,740 - Neustadt , et al. December 16, 2
2008-12-16
Neuropeptide receptor modulators
Grant 7,459,450 - Zhu , et al. December 2, 2
2008-12-02
Adenosine A2a Receptor Antagonists
App 20080255156 - Clasby; Martin C. ;   et al.
2008-10-16
Heterocyclic aspartyl protease inhibitors
App 20080200445 - Zhu; Zhaoning ;   et al.
2008-08-21
Preparation and use of compounds as protease inhibitors
App 20080176868 - Stamford; Andrew ;   et al.
2008-07-24
Preparation and use of compounds as protease inhibitors
App 20080113957 - McKittrick; Brian ;   et al.
2008-05-15
2-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A.sub.2a receptor antagonists
Grant 7,368,449 - Neustadt , et al. May 6, 2
2008-05-06
Azetidinone Derivatives and Methods of Use Thereof
App 20080076750 - Aslanian; Robert G. ;   et al.
2008-03-27
Treating Pain, Diabetes, And Disorders Of Lipid Metabolism
App 20080070892 - Harris; Joel M. ;   et al.
2008-03-20
Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction
Grant 7,312,223 - Ghosal , et al. December 25, 2
2007-12-25
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
Grant 7,309,704 - Stamford , et al. December 18, 2
2007-12-18
Aspartyl Protease Inhibitors
App 20070287692 - Wu; Yusheng ;   et al.
2007-12-13
Xanthine phosphodiesterase V inhibitors
Grant 7,268,141 - Chackalamannil , et al. September 11, 2
2007-09-11
Heterocyclic aspartyl protease inhibitors
App 20070072852 - Zhu; Zhaoning ;   et al.
2007-03-29
2-Heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
App 20070066620 - Neustadt; Bernard R. ;   et al.
2007-03-22
Aspartyl protease inhibitors
App 20070060575 - Zhu; Zhaoning ;   et al.
2007-03-15
Preparation and use of compounds as aspartyl protease inhibitors
App 20070010667 - McKittrick; Brian ;   et al.
2007-01-11
Aspartyl protease inhibitors
App 20060287294 - Zhu; Zhaoning ;   et al.
2006-12-21
Aspartyl protease inhibitors
App 20060281730 - Zhu; Zhaoning ;   et al.
2006-12-14
Macrocyclic heterocyclic aspartyl protease inhibitors
App 20060281729 - Iserloh; Ulrich ;   et al.
2006-12-14
Heterocyclic aspartyl protease inhibitors
App 20060111370 - Zhu; Zhaoning ;   et al.
2006-05-25
Neuropeptide receptor modulators
App 20060089351 - Zhu; Zhaoning ;   et al.
2006-04-27
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
App 20060030588 - Stamford; Andrew ;   et al.
2006-02-09
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
Grant 6,982,267 - Stamford , et al. January 3, 2
2006-01-03
Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
App 20050239795 - Neustadt, Bernard R. ;   et al.
2005-10-27
2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
App 20050222164 - Neustadt, Bernard R. ;   et al.
2005-10-06
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
Grant 6,946,476 - Stamford , et al. September 20, 2
2005-09-20
Cyclic amine bace-1 inhibitors having a benzamide substituent
App 20050119227 - Cumming, Jared N. ;   et al.
2005-06-02
2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
Grant 6,897,217 - Neustadt , et al. May 24, 2
2005-05-24
Cyclic amine BACE-1 inhibitors having a heterocyclic substituent
App 20050043290 - Cumming, Jared N. ;   et al.
2005-02-24
Substituted urea neuropeptide Y Y5 receptor antagonists
App 20050038100 - Greenlee, William J. ;   et al.
2005-02-17
Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction
App 20050026939 - Ghosal, Anima ;   et al.
2005-02-03
2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
App 20040220194 - Neustadt, Bernard R. ;   et al.
2004-11-04
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
App 20040006086 - Stamford, Andrew ;   et al.
2004-01-08
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
App 20030055062 - Stamford, Andrew ;   et al.
2003-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed